by Liane Schmidt, PhD | Oct 25, 2022 | Uncategorized
Evaluation of Early Ketamine Effects on Belief-Updating Biases in Patients With Treatment-Resistant Depression Presented on Tuesday 25th October 2022 | 05:30 PM (BST UK time) | 06:30 PM (CEST France time) | 12:30 PM (EDT NY time) | 09:30 AM (PDT LA time) Hugo...
by Rebecca B. Price, PhD | Oct 11, 2022 | Uncategorized
A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant Effect of a Single Ketamine Infusion: A Randomized Clinical Trial Presented on Tuesday 11th October 2022 | 05:30 PM (UK time) | 12:30 PM (EDT NY time) | 09:30 AM (PDT LA time) Rebecca B. Price,...
by Philip Wolfson, MD | Sep 27, 2022 | Uncategorized
The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women: Quantification of Ketamine and Metabolites Presented on Tuesday 27th September 2022 | 12.30pm EST | 5.30pm UK Philp Wolfson, Rob Cole, Kara Lynch, Cassandra Yun, Jason Wallach, Julane Andries,...
by Juan Pablo Lopez, PhD | Sep 13, 2022 | Uncategorized
Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2 Presented on Tuesday 13th September 2022 | 12.30pm EST | 5.30pm UK Juan Pablo Lopez, Malte D Lücken, Elena Brivio, Stoyo Karamihalev, Aron Kos, Carlo De Donno, Asaf...
by Thomas Derrick Hull, PhD | Jul 26, 2022 | Uncategorized
At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial Presented on Tuesday 26th July 2022 | 12.30pm EST | 5.30pm UK Thomas D Hull,...
by David Mathai, MD and Scott Lee, MD | Jul 12, 2022 | Uncategorized
Mapping consent practices for outpatient psychiatric use of ketamine Presented on Tuesday 12th July 2022 | 12.30pm EST | 5.30pm UK David S Mathai, Scott M Lee, Victoria Mora, Kelley C O’Donnell, Albert Garcia-Romeu, Eric A Storch. J Affect Disord. 2022 Sep...
